Home
Conditions
Herpesviridae Infections

Clinical trial condition

Herpesviridae Infections

Explore clinical trials studying Herpesviridae Infections. Study availability and eligibility vary by location and protocol.

1,824 public trials 252 recruiting studies

Refine in advanced search Browse all conditions

Herpesviridae Infections trial results

Completed

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00436618

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic - Jacksonville Jacksonville, Florida, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00003396

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +60 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003398

Conditions: Anemia, Blast Crisis, Blood Protein Disorders, +64 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

View Trial Details

Completed

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

NCT00005946

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +55 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

View Trial Details

Completed

Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma

NCT00392990

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +14 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

John H. Stroger Cook County Hospital Chicago, Illinois, United States

Rush University Medical Center Chicago, Illinois, United States

Loyola University Medical Center Maywood, Illinois, United States

View Trial Details

Completed

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

NCT01136395

Conditions: DNA Virus Infections, Epstein-Barr Virus Infections, Herpesviridae Infections, +8 more
Locations: Department of Internal Medicine, University of Giessen Giessen, Germany

View Trial Details

Completed

Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age

NCT02979639

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: GSK Investigational Site Oakland, California, United States

GSK Investigational Site Aurora, Colorado, United States

GSK Investigational Site Colorado Springs, Colorado, United States

GSK Investigational Site Colorado Springs, Colorado, United States

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

NCT01229267

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)

NCT01254630

Conditions: DNA Virus Infections, Hematologic Diseases, Hematologic Neoplasms, +8 more
Locations: Not specified

View Trial Details

Completed

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01529827

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +179 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Herpesviridae Infections

Herpesviridae Infections trial results

Related conditions